Abaxis has entered into a definitive agreement with a medical supplies sourcing and support company to deliver its 300 Piccolo Xpress chemistry analyzers. The biotechnology company will use CLIA waived Piccolo Xpress instruments in the ...
JS Genetics has launched a new proprietary buccal swab test, XCAT-KS, to diagnose Klinefelter syndrome (KS) and other male sex chromosome aneuploidies. XCAT-KS is a PCR / pyrosequencing based bloodless test which identifies KS and ...
Tags: clinical research, clinical technology, proprietary DNA diagnostic tests
US-based Trovagene has developed a urine-based molecular diagnostic test to detect and monitor cancer mutations. The test quantitatively detects KRAS mutations in transrenal DNA,which may be originated from both normal and diseased cells. ...
Tags: Trovagene, molecular diagnostic test, cancer mutations, cancer monitoring
Nicox has announced the US launch of its rapid point-of-care diagnostic test, designed for the detection of acute conjunctivitis. The FDA-cleared and CLIA-waived assay, AdenoPlus, uses its four-step process to detect adenovirus and ...
Tags: rapid point-of-care diagnostic test, FDA, medical devices
Genewiz, a provider of DNA services, has obtained clinical laboratory improvement amendments (CLIA) certification. The certification allows the company to expand its clinical genomic testing solutions, thus contributing to advancements in ...
Tags: DNA services, CLIA Certification, clinical genomic testing